Advertisement

U.S. Markets open in 4 hrs 57 mins

S&P Futures
5,902.00
+15.00(+0.25%)
Dow Futures
43,318.00
-24.00(-0.06%)
Nasdaq Futures
20,461.00
+111.50(+0.55%)
Russell 2000 Futures
2,307.00
+2.60(+0.11%)
Crude Oil
70.38
-0.01(-0.01%)
Gold
2,698.40
+7.10(+0.26%)

ImmunoPrecise Antibodies Ltd. (IPA)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

0.5611

-0.0089

(-1.56%)

At close: 04:00PM EDT

0.5783

+0.02

(+3.07%)

After hours:

05:01PM EDT

Trade prices are not sourced from all markets

All

Business Wire
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design
VICTORIA, British Columbia, October 10, 2024--ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today celebrates the recent Nobel Prize in Chemistry awarded to David Baker of the University of Washington, Seattle, WA, USA, "for computational protein design," and jointly to Demis Hassabis and John M. Jumper of Google DeepMind, London, UK, "for protein structure prediction." This accolade highlights the vital role of
GuruFocus.com
ImmunoPrecise Antibodies Ltd (IPA) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amid ...
ImmunoPrecise Antibodies Ltd (IPA) reports a 19% revenue increase and significant cash burn reduction, while navigating profitability pressures and market valuation disconnects.